Akèy › Twoub Konsomasyon Alkòl (AUD)
Etid klinik pou Twoub Konsomasyon Alkòl (AUD) ap rekrite nan Etazini
140 etid pou Twoub Konsomasyon Alkòl (AUD) ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New Haven, CT17 etid
- Washington, DC14 etid
- Baltimore, MD11 etid
- Providence, RI8 etid
- Los Angeles, CA7 etid
- Philadelphia, PA7 etid
- Portland, OR5 etid
- Chicago, IL5 etid
- San Diego, CA5 etid
- New York City, NY5 etid
- Seattle, WA5 etid
- Boston, MA5 etid
- Aurora, CO5 etid
- Columbus, OH5 etid
- Dallas, TX5 etid
- Houston, TX4 etid
- Mountain View, CA4 etid
- Charleston, SC4 etid
- Atlanta, GA4 etid
- Minneapolis, MN4 etid
- Lexington, KY3 etid
- Indianapolis, IN3 etid
- Little Rock, AR3 etid
- Cleveland, OH3 etid
- Ann Arbor, MI3 etid
- Orlando, FL3 etid
- Madison, WI3 etid
- Parma, OH3 etid
- Miami, FL3 etid
- San Francisco, CA3 etid
Pa eta
- Alabama3 etid
- Arizona4 etid
- Arkansas4 etid
- Colorado6 etid
- Connecticut18 etid
- Florid6 etid
- Georgia5 etid
- Illinois7 etid
- Indiana4 etid
- Kalifòni15 etid
- Kentucky5 etid
- Maryland24 etid
- Massachusetts8 etid
- Michigan7 etid
- Minnesota4 etid
- New York10 etid
- Ohio11 etid
- Oklahoma3 etid
- Oregon6 etid
- Pennsylvania9 etid
- Rhode Island8 etid
- South Carolina5 etid
- Texas11 etid
- Utah3 etid
- Virginia4 etid
- Washington8 etid
- Wisconsin3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving
Ap rekriteFaz 2/3
Laj 21 a 65 · Tout sèks · Mizajou Oct 2, 2026 · NCT07148843Hepatic Lipid Metabolism-Alcohol Use Disorder
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT07191561Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Oct 2, 2026 · NCT05677321Environment and Alcohol: A Pilot Study
Ap rekriteFaz 1Volontè an sante akeyi
Laj 21 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT06860607SMART-r: Substance Monitoring and Active Relapse Tracking Repository
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Oct 2, 2026 · NCT06676059Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT06484075Intranasal Insulin for Treatment of Alcohol Use Disorder
Ap rekriteFaz 1/2
Laj 21 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT05988632DEVELOPMENT OF A NOVEL PEER RECOVERY SUPPORTER TRAINING PLATFORM
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07044531tAN for Substance Use Disorder
Ap rekrite
Laj 18 a 64 · Tout sèks · Mizajou Sep 28, 2026 · NCT07281261Greek Connections Study
Ap rekriteVolontè an sante akeyi
Laj 18 a 29 · Tout sèks · Mizajou Sep 24, 2026 · NCT07839026A Study of Brenipatide in Participants With Alcohol Use Disorder
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07219953A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07219966A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05619185Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
Ap rekriteFaz 1
Laj 21 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06335407Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)
Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT07218354Spironolactone in Alcohol Use Disorder (SAUD)
Ap rekriteFaz 1
Laj 21 a 99 · Tout sèks · Mizajou Sep 21, 2026 · NCT05807139Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT07214207PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Sep 18, 2026 · NCT06795581Imaging Mitochondrial Complex-I in Alcohol Use Disorder
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Sep 17, 2026 · NCT07825818Exercise Training Decreases Alcohol Consumption and Tissue Injury by an FGF21-dependent Mechanism
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07824089Characterization Imaging Instruments in Alcoholics and Non-Alcoholics
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT02108080PT150 Drug for Use in Alcohol Use Disorder
Ap rekriteFaz 1
Laj 21 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT06712602The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06319872Cannabidiol and Alcohol Use Disorder Phenotypes
Ap rekriteFaz 2
Laj 21 a 65 · Tout sèks · Mizajou Sep 16, 2026 · NCT07279558Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06518785Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.